SERCA Pharmaceuticals is Drug Discovery in Norway that focus on reperfusion injury business. Founded in 2018. They cover business area such as developer, drug treatment, injury, heart attack, IRI, reperfusion, acute myocardial infarction.
2018
( 6 years old in 2024 )
Reperfusion Injury
-
C/o Evolve
Vollsveien 4B
1366 Lysaker
Norway
Private
developerdrug treatmentinjuryheart attackIRIreperfusionacute myocardial infarction
* We use standard office opening hours in near SERCA Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SERCA Pharmaceuticals is Drug Discovery business from Norway that founded in 2018 (6 years old in 2024), SERCA Pharmaceuticals business is focusing on Reperfusion Injury.
SERCA Pharmaceuticals headquarter office and corporate office address is located in C/o Evolve Vollsveien 4B 1366 Lysaker Norway.
SERCA Pharmaceuticals was founded in Norway.
In 2024, SERCA Pharmaceuticals is currently focus on reperfusion injury sector.
Above is snippet of Google Trends for "reperfusion injury" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SERCA Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
